{"version":"1.0","type":"link","title":"Cost-effectiveness of first-line immune checkpoint inhibitor therapies, alone or combined with targeted agents, for unresectable hepatocellular carcinoma in China: an economic evaluation using network meta-analysis.","author_name":"Li W 외","author_url":"https://prs-insight.online/author/Li%20W","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/107749","thumbnail_width":1200,"thumbnail_height":630}